The submission by the company came in response to a query by Justice Vibhu Bakhru as to what was it doing in cases where patients want more...

The court's direction came after the company said it has verified that these patients have undergone revision surgery and it was voluntaril...

The apex court on October 5 had asked the Centre to file its response to the PIL alleging that "faulty" and "deadly" hip implants have been...

The development follows a letter sent by the country's apex drug regulator on Tuesday directing it to comply with "all" recommendations of ...

This committee has been formed upon recommendations of another expert group set up last year to look into the issue of these implants.

J&J has already paid $2.5 billion in settlements in the US, while Indian victims may receive a minimum payout of Rs 20 lakh each after an a...

Mahesh Zagade first initiated investigations into Johnson & Johnson’s faulty hip implants in 2011.

J&J, through subsidiary DePuy Orthopaedics, had issued a global recall of the implant system, called ASR Hip System, in 2010 after it recei...

The reason it has taken so long to arrive at this decision is because there is currently no provision to compensate patients for drugs and ...

In a bid to grow its presence in the Indian orthopaedic devices market, US healthcare giant Johnson & Johnson (J&J) is planning to roll out...